Latest News about SYNH
Recent news which mentions SYNH
   12 Health Care Stocks Moving In Tuesday's Pre-Market Session
   
  
  
  August 02, 2022
  From Benzinga
 
   Earnings Scheduled For August 2, 2022
   
  
  
  August 02, 2022
  From Benzinga
 From Benzinga
 
   Earnings Scheduled For April 29, 2022
   
  
  
  April 29, 2022
  From Benzinga
 
   Stocks That Hit 52-Week Lows On Tuesday
   
  
  
  April 26, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Look for this group of stocks to surge when risk aversion fades, says fund manager, who offers five stock ideas
   
  
  
  March 16, 2022
  From MarketWatch
 
   Looking Into Syneos Health's Return On Capital Employed
   
  February 18, 2022
  Tickers 
   SYNH
  
  
  From Benzinga
 
   The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
   
  
  
  February 17, 2022
  From Benzinga
 
   Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance
   
  February 17, 2022
  Tickers 
   SYNH
  
  
  From Benzinga
 
   Earnings Scheduled For February 17, 2022
   
  
  
  February 17, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
   
  
  
  December 15, 2021
  From Benzinga
 
   Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg
   
  
  
  November 12, 2021
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
   
  
  
  November 05, 2021
  From Benzinga
 
   Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript
   
  November 03, 2021
  Tickers 
   SYNH
  
  
  From Motley Fool
 
   The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
   
  
  
  November 03, 2021
  From Benzinga
 
   Earnings Scheduled For November 3, 2021
   
  
  
  November 03, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
   
  
  
  October 31, 2021
  From Benzinga
 
   The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
   
  
  
  October 13, 2021
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
